Scienta Lab is a Paris-based company building predictive models of the human immune response to improve drug development in immunology and inflammation. The company develops EVA, a multimodal foundation model trained on transcriptomics and histology data, with the goal of bridging the gap between preclinical models and human biology so that researchers can identify promising immunology and inflammation drug candidates earlier in the development pipeline.
Models (1)
—20—
Cross-species multimodal foundation model of immunology and inflammation, harmonizing transcriptomics and histology into patient-level embeddings.
Single-cellRNAPathology